The Talent Scarcity Problem
There is no polite way to say this: the global talent pool for Head of Radiochemistry is extremely small. Radiochemistry sits at the intersection of organic chemistry, nuclear physics, and GMP manufacturing.
The number of people who have genuine hands-on experience synthesising radiolabelled compounds under GMP conditions, managing a radiochemistry team, and navigating dual regulatory oversight is measured in the low hundreds globally. When you narrow that pool to people who have done this at commercial scale rather than academic scale, you are looking at a fraction of that number.
Where the Candidates Are
The qualified candidate pool clusters in three geographies:
The European nuclear medicine corridor: Germany, the Netherlands, Belgium, and Switzerland, where companies like ITM, Curium, and Novartis have built radiochemistry teams.
The US Northeast and Midwest: Anchored by academic medical centres and commercial radiopharma companies in the Boston, New York, and Indianapolis corridors.
The emerging US South and West pool: Driven by new facility builds from companies like Lantheus, ARTBIO, and Convergent Therapeutics.
Candidates outside these clusters exist but are rare and typically require relocation packages that add 15-25% to total cost of hire.
Compensation Reality
Head of Radiochemistry compensation has moved significantly in the last 24 months. In the US, base salary ranges now sit between $220,000 and $290,000 with total compensation reaching $280,000 to $380,000.
The premium reflects scarcity: there are more funded radiopharma programmes than there are qualified radiochemistry leaders. European ranges are lower in absolute terms but have seen proportionally larger increases, particularly in Germany and the Netherlands.
Assessment Criteria That Matter
When assessing a Head of Radiochemistry candidate, three dimensions matter more than publication history or academic pedigree:
1. GMP translation. Can they demonstrate that they have taken a radiochemistry process from bench scale to GMP production? Many candidates have excellent academic credentials but have never operated under cGMP.
2. Isotope breadth. Have they worked with multiple isotopes (Lu-177, Ac-225, Pb-212, At-211) or are they a single-isotope specialist? The industry is diversifying rapidly into alpha emitters, and leaders who only know one system face a steep learning curve.
3. Regulatory navigation. Have they personally managed interactions with nuclear regulatory authorities, not just pharmaceutical ones? The dual oversight model is unique to radiopharma and candidates who have not navigated it before consistently underestimate its complexity.
The Search Timeline
Expect a retained search for a Head of Radiochemistry to take 10-16 weeks. The extended timeline reflects the small talent pool, the high proportion of passive candidates, and the complexity of relocation discussions. Counter-offers are common and should be anticipated in the offer strategy from day one.